Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dumitru Chesov

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Lancet Regional Health. Europe|July 23, 2025
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyYousra Kherabi, Ole Skouvig Pedersen, Christoph Lange, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 23, 2023
Recent advances in the treatment of tuberculosisIlaria Motta, Martin Boeree, Dumitru Chesov, et al.
The European Respiratory Journal|December 13, 2024
Tuberculosis in adult migrants in Europe: a TBnet consensus statementHeinke Kunst, Berit Lange, Olga Hovardovska, et al.
Frontiers in Immunology|October 29, 2020
Perspective for Precision Medicine for TuberculosisChristoph Lange, Rob Aarnoutse, Dumitru Chesov, et al.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.
The Lancet. Global Health|July 19, 2024
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosisDaniela Cirillo, Richard Anthony, Sebastien Gagneux, et al.
The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Lancet Regional Health. Europe|July 23, 2025
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyYousra Kherabi, Ole Skouvig Pedersen, Christoph Lange, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 23, 2023
Recent advances in the treatment of tuberculosisIlaria Motta, Martin Boeree, Dumitru Chesov, et al.
The European Respiratory Journal|December 13, 2024
Tuberculosis in adult migrants in Europe: a TBnet consensus statementHeinke Kunst, Berit Lange, Olga Hovardovska, et al.
Frontiers in Immunology|October 29, 2020
Perspective for Precision Medicine for TuberculosisChristoph Lange, Rob Aarnoutse, Dumitru Chesov, et al.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.
The Lancet. Global Health|July 19, 2024
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosisDaniela Cirillo, Richard Anthony, Sebastien Gagneux, et al.
The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
Pageof 4